Efficacy and Safety of Tonic Motor Activation (TOMAC) for Medication-refractory Restless Legs Syndrome: A Randomized Clinical Trial.

Richard K BoganAsim RoyJerrold KramJoseph OjileRussell RosenbergJ Douglas HudsonH Samuel ScheullerJohn W WinkelmanJonathan D Charlesworth

Published in: Sleep (2023)

TOMAC was safe, well tolerated, and reduced symptoms of RLS in medication-refractory patients. TOMAC is a promising new treatment for this population.

Keyphrases

end stage renal disease
ejection fraction
healthcare
newly diagnosed
chronic kidney disease
prognostic factors
adverse drug
case report
patient reported outcomes
combination therapy